You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Lymphoid, Acute

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

H19 in Acute Lymphoblastic Leukemia.

Not yet recruiting
  • Acute Lymphoid Leukemia
    • (no location specified)
    Jul 11, 2023

    Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

    Recruiting
    • Acute Lymphoid Leukemia
    • +3 more
    • São Paulo, SP, Brazil
      Instituto do Cancer do Estado de Sao Paulo
    Jul 24, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • Acute Lymphoblastic Leukemia With Failed Remission
    • São Paulo, SP, Brazil
      Instituto do Cancer do Estado de Sao Paulo
    Sep 12, 2023

    Anti-mullerian Hormone in Acute Lymphoblastic Leukemia

    Recruiting
    • Acute Lymphoblastic Leukemia
      • Trieste, Italy
        IRCCS Burlo Garofolo
      Mar 20, 2023

      Acute Lymphoid Leukemia, Acute Myeloid Leukemia in Children Trial in Tours (Biological sampling in patients, Biological sampling

      Not yet recruiting
      • Acute Lymphoid Leukemia
      • Acute Myeloid Leukemia in Children
      • Biological sampling in patients
      • Biological sampling in control patients
      • Tours, France
      • +2 more
      Mar 17, 2023

      Lymphoblastic Leukemia Trial in Palo Alto (Dasatinib)

      Not yet recruiting
      • Lymphoblastic Leukemia
      • Palo Alto, California
        Stanford University
      Aug 14, 2023

      Pediatric Acute Lymphoblastic Leukemia, Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sleep ALL Night)

      Not yet recruiting
      • Pediatric Acute Lymphoblastic Leukemia
      • +2 more
      • Sleep ALL Night
      • Boston, Massachusetts
      • +1 more
      May 10, 2023

      B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

      Recruiting
      • B-Cell Lymphoblastic Leukemia
      • Acute Lymphoblastic Leukemia
      • Tampa, Florida
        Moffitt Cancer Center
      Nov 28, 2023

      Enteral Nutrition in Children Treated for Acute Lymphoblastic

      Active, not recruiting
      • Leukemia, Lymphoblastic
      • enteral or parenteral nutritional support
      • Vandœuvre-lès-Nancy, France
        CHRU Nancy
      Oct 26, 2023

      Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)

      Active, not recruiting
      Has Results
      • Lymphoid Leukemia
      • +3 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Dec 30, 2022

      Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

      Recruiting
      • Non Hodgkin Lymphoma
      • +2 more
      • Fully human anti CD19 CAR-T Cell Dose
      • +2 more
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Case Comprehensiv
      Oct 4, 2022

      B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

      Not yet recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • HY004
      • +2 more
      • (no location specified)
      Aug 18, 2023

      Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

      Not yet recruiting
      • Leukemia, Lymphoid
      • Chengdu, Sichuan, China
        West China Hospital of Sichuan University
      Oct 3, 2023

      Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

      Recruiting
      • Leukemia, Lymphoid
      • Chengdu, Sichuan, China
        West China Hospital of Sichuan University
      Oct 27, 2023

      Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

      Recruiting
      • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
      • Olverembatinib plus venetoclax and dexamethasone
      • Xi'an, Shannxi, China
        Department of Hematology, Xijing Hospital, Fourth Military Medic
      Oct 9, 2023

      B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • QH103 Cell Injection
      • +2 more
      • Hefei, Anhui, China
        Anhui Provincial Hospital
      Sep 21, 2023

      B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

      Not yet recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • (no location specified)
      Oct 10, 2023

      ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)

      Not yet recruiting
      • ALL, Childhood B-Cell
      • +2 more
      • Tafasitamab
      • (no location specified)
      Nov 25, 2022

      Refractory B-cell Acute Lymphoblastic Leukemia Trial in Houston (Mosunetuzumab)

      Not yet recruiting
      • Refractory B-cell Acute Lymphoblastic Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 18, 2023

      B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

      Not yet recruiting
      • B Precursor Acute Lymphoblastic Leukemia
      • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
      • (no location specified)
      Sep 25, 2023

      T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

      Not yet recruiting
      • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
      • CD7-CART01
      • (no location specified)
      Sep 26, 2023

      Determining the Mechanisms of Loss of CAR T Cell Persistence

      Not yet recruiting
      • Acute Lymphoblastic Leukemia With Failed Remission
      • +4 more
        • (no location specified)
        Mar 29, 2023

        Acute Lymphoid Leukemia Trial in Seoul (Blincyto)

        Not yet recruiting
        • Acute Lymphoid Leukemia
        • Seoul, Gangnam-gu, Korea, Republic of
        • +4 more
        Apr 12, 2023

        Infective Complications and Outcome of ALL Treated With INO

        Not yet recruiting
        • Acute Lymphoblastic Leukemia
        • +4 more
          • (no location specified)
          Aug 29, 2023

          Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)

          Not yet recruiting
          • Lymphoblastic Leukemia
          • Palo Alto, California
            Stanford University
          Apr 27, 2023